IDEXX Laboratories Inc IX1
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €452.80
- Day Range
- €456.20–458.00
- 52-Week Range
- €431.80–663.20
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 78.78M
- Market Cap
- $36.00B
- Volume/Avg
- 4 / 8
Key Statistics
- Price/Earnings (Normalized)
- 39.63
- Price/Sales
- 9.38
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.77%
Company Profile
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 11,000
- Website
- https://www.idexx.com
Competitors
Valuation
|
Metric
|
IX1
|
MRK
|
ZTS
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.63 | 45.36 | 11.37 |
Price/Book Value | 25.61 | 8.57 | 9.84 |
Price/Sales | 9.38 | 5.43 | 3.38 |
Price/Cash Flow | 28.09 | 16.30 | 10.05 |
Price/Earnings
IX1
MRK
ZTS
Financial Strength
|
Metric
|
IX1
|
MRK
|
ZTS
|
|---|---|---|---|
Quick Ratio | 0.73 | 0.71 | 1.57 |
Current Ratio | 1.17 | 1.32 | 3.08 |
Interest Coverage | 38.63 | 4.28 | 14.29 |
Quick Ratio
IX1
MRK
ZTS
Profitability
|
Metric
|
IX1
|
MRK
|
ZTS
|
|---|---|---|---|
Return on Assets (Normalized) | 35.22% | 6.27% | 18.78% |
Return on Equity (Normalized) | 76.64% | 16.68% | 70.42% |
Return on Invested Capital (Normalized) | 45.73% | 9.82% | 23.70% |
Return on Assets
IX1
MRK
ZTS
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|?r@QGw@ | LOCK|?YS | $243B | |||
| Danaher Corp
DHR
| LOCK|?!wz<DJ@ | LOCK|FF@ | $155B | |||
| Agilent Technologies Inc
A
| LOCK|dg^W?># | LOCK|r$ | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|@s>L?m | LOCK|pL!@ | $43B | |||
| Waters Corp
WAT
| LOCK|m!nYJ^v | LOCK|@f! | $43B | |||
| Illumina Inc
ILMN
| LOCK|D?^?d< | LOCK|&TTL | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|xYh&xx> | LOCK|LJ^ | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|jq>PQ$F | LOCK|dht@ | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|&V^<b@g | LOCK|#<lk^ | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|$!b@Phs? | LOCK|$p?? | $25B |
United States